Affymetrix Announces Preliminary Revenue for First Quarter 2013
April 9, 2013
SANTA CLARA, Calif. -- Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. The Company expects to report cash-on-hand of at least $38 million as of March 31, 2013. [...]
IBM and CLC bio deliver combined turnkey genomics sequencing analytics solution
April 9, 2013
Boston, Massachusetts, USA -- Today at the Bio-IT World conference in Boston, IBM and CLC bio announced a combined turnkey next generation sequencing data analytics solution. The combined platform is a scalable end-to-end solution that integrates a computing cluster build on advanced IBM hardware, CLC Genomics Server software for large-scale genomics sequencing data analysis, and [...]
April 9, 2013
Boston, Mass. -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of Genedata Screener® 11, a single-platform screening data analysis system with built-in business logic for standardizing and automating screening workflows. The new Genedata Screener now supports compound combination screens to analyze compound synergy [...]
HBIO Announces Postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc.
April 9, 2013
HOLLISTON, Mass., -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that the planned initial public offering by its wholly-owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc., or HART, has been postponed due to market [...]
Rockland Immunochemicals Acquires Epi-Plus® Product Line
April 9, 2013
GILBERTSVILLE, Pa.-- Rockland Immunochemicals, Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, today announced the acquisition of the Epi-Plus® antibody product line from 21st Century Biochemicals, Inc. Epi-Plus® antibodies are widely regarded as the most well validated antibodies available for epigenetics research. All Epi-Plus® [...]
Wyatt Calypso Succeeds in ABRF-MIRG Study
April 9, 2013
SANTA BARBARA, CALIFORNIA - Wyatt Technology is pleased to report the success of the Calypso composition-gradient multi-angle light scattering (CG-MALS) system in a study conducted by the Molecular Interactions Research Group (MIRG) of the Association of Biomolecular Research Facilities (ABRF). The conclusions of the 2012 MIRG study were announced at the ABRF 2013 annual meeting [...]
April 9, 2013
In today’s laboratories, experimental datasets are growing larger, and critical tasks such as data storage, processing, mining and sharing have become increasingly cumbersome, error prone and expensive. The revolutionary i3D Enterprise Service offered by Shimadzu Scientific Instruments and Integrated Analysis Inc. overcomes these challenges by integrating storage, processing and data mining in an enterprise-level private [...]
908 Devices and IQT Enter Strategic Partnership to Develop New Mass Spectrometry Analyzers
April 9, 2013
Boston, MA: 908 Devices, an innovator in field-portable chemical analysis, today announced it has entered into a strategic partnership with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. The investment will contribute to 908 Devices’ efforts to build rugged, handheld mass spectrometry [...]
April 9, 2013
Salisbury, UK,: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being applied in the development of future diagnostic and theranostic solutions for early diagnosis, drug delivery and treatment of cancer at the School of Medicine and CRANN, Trinity College Dublin, Ireland. The School of Medicine (Institute of Molecular Medicine) and CRANN (the Centre for [...]
April 9, 2013
SHANGHAI, China –- PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced a new collaboration with the National Center for Drug Screening (NCDS) to advance personalized medicine and drug profiling in China. Through sharing knowledge, expertise and innovative capabilities, the two organizations will establish a [...]
